← Leaderboard
RARE
Ticker
RARE
Congressional Trades
9
by 1 members
Buys
9
100%
Sells
0
0%
Total Volume
$72K
midpoint
Unique Traders
1
members
Party Breakdown
Democrats9 · 100%
Republicans0 · 0%
Party Trading Divergence
Democrat vs. Republican buy / sell pressure by monthHIGH DIVERGENCEBar length = total trades. Color = net sentiment — green = net buying, red = net selling. Months with no activity hidden.
Democrat ←
Month
→ Republican
3▲
Jul '25
—
2▲
Aug '25
—
2▲
Feb '26
—
2▲
Mar '26
—
Democrats9▲0▼Net buyers
vs
Republicans0▲0▼Neutral
Net buyingNet selling⚡ Party split
💼 Lobbying Filings
all →- 2026-04-20$10KULTRAGENYX PHARMACEUTICALIssues related to drug development and market access.
- 2026-04-20$0ULTRAGENYX PHARMACEUTICALn/a termination report
- 2026-04-20$0ULTRAGENYX PHARMACEUTICAL INC.Issues relating to rare disease and patient access.
- 2026-04-17$440KULTRAGENYX PHARMACEUTICAL INC.Issues related to drug development, access and reimbursement for rare and ultra rare diseases. Issues related to drug development, access and reimbursement for rare and ultra rare diseases. Issues related to drug development, access and reimbursement for rare and ultra rare diseases.
- 2026-04-17$60KULTRAGENYX PHARMACEUTICAL INC.Issues relating to rare disease and patient access. H.R.1262/S. 932 - Give Kids a Chance Act of 2025. FY 2027 Appropriations.
- 2026-04-17$0ULTRAGENYX PHARMACEUTICALIssues related to drug development and market access.
- 2026-03-30$0ULTRAGENYX PHARMACEUTICAL INC.Issues relating to rare disease and patient access.
- 2026-01-16$130KULTRAGENYX PHARMACEUTICAL INC.Issues related to drug development, access and reimbursement for rare and ultra rare diseases. Issues related to drug development, access and reimbursement for rare and ultra rare diseases. Issues related to drug development, access and reimbursement for rare and ultra rare diseases.
- 2026-01-16$60KULTRAGENYX PHARMACEUTICAL INC.Issues relating to rare disease and patient access. H.R.1262/S. 932 - Give Kids a Chance Act of 2025.
- 2026-01-15$38KULTRAGENYX PHARMACEUTICAL- ultrarare disease - newborn screening - pediatric priority review voucher
Congressional Momentum
buy vs. sell pressureACCUMULATINGScore 0–100: above 50 = net buying pressure, below 50 = net selling. Signal based on last 90 days.
Last 30 Days
No trades
Last 90 Days
▲100
4 buys4 total0 sells
$32K buys · $0 sells
All-Time
▲100
9 buys9 total0 sells
$72K buys · $0 sells
Cumulative Net Position (buy vol − sell vol)
+$72K
2025-079 trades plotted2026-03
Trade Activity Timeline
Congressional buys & sells by month · last 4 months w/ activity
25/07
25/08
26/02
26/03
BuysSellsOtherHigh-volume month
All Disclosed Trades
| Date | Member | Action | Amount | Filing Delay |
|---|---|---|---|---|
| 2026-03-03 | DGilbert Cisneros | BUY | $1K – $15K | 36d |
| 2026-03-03 | DGilbert Cisneros | BUY | $1K – $15K | 35d |
| 2026-02-18 | DGilbert Cisneros | BUY | $1K – $15K | 20d |
| 2026-02-18 | DGilbert Cisneros | BUY | $1K – $15K | 19d |
| 2025-08-08 | DGilbert Cisneros | BUY | $1K – $15K | 38d |
| 2025-08-08 | DGilbert Cisneros | BUY | $1K – $15K | 35d |
| 2025-07-15 | DGilbert Cisneros | BUY | $1K – $15K | 31d |
| 2025-07-15 | DGilbert Cisneros | BUY | $1K – $15K | 30d |
| 2025-07-15 | DGilbert Cisneros | BUY | $1K – $15K | 29d |